Alliancebernstein L.P. Rigel Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $13,107 - $17,027	-12,250 Reduced 3.75%	314,730 $339,000
Q2 2023 Aug 15, 2023	BUY	$1.12 - $1.82 $18,860 - $30,648	16,840 Added 5.43%	326,980 $421,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $10,519 - $186,830	15,700 Added 5.33%	310,140 $465,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $91,187 - $434,159	136,100 Added 85.95%	294,440 $333,000
Q1 2022 May 13, 2022	BUY	$2.22 - $3.45 $1,332 - $2,070	600 Added 0.38%	158,340 $473,000
Q2 2021 Jul 30, 2021	BUY	$3.09 - $4.54 $72,306 - $106,236	23,400 Added 17.42%	157,740 $685,000
Q1 2021 May 06, 2021	SELL	$3.35 - $4.93 $98,490 - $144,942	-29,400 Reduced 17.96%	134,340 $459,000
Q4 2020 Feb 08, 2021	BUY	$2.35 - $3.74 $31,490 - $50,116	13,400 Added 8.91%	163,740 $573,000
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $152,902 - $354,767	-85,900 Reduced 36.36%	150,340 $361,000
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.05 $34,122 - $49,609	24,200 Added 11.41%	236,240 $432,000
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $14,180 - $22,794	8,700 Added 4.28%	212,040 $397,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $22,826 - $29,493	11,300 Added 5.88%	203,340 $531,000
Q1 2019 May 14, 2019	SELL	$2.0 - $2.65 $2.3 Million - $3.05 Million	-1,150,000 Reduced 85.69%	192,040 $494,000
Q3 2018 Nov 08, 2018	BUY	$2.6 - $3.59 $455,000 - $628,250	175,000 Added 15.0%	1,342,040 $4.31 Million
Q2 2018 Aug 13, 2018	BUY	$2.83 - $4.11 $1.39 Million - $2.02 Million	491,000 Added 72.63%	1,167,040 $3.3 Million
Q1 2018 May 14, 2018	BUY	$3.54 - $4.54 $612,420 - $785,420	173,000 Added 34.39%	676,040 $2.39 Million
Q4 2017 Feb 13, 2018	BUY	$3.23 - $4.3 $26,809 - $35,690	8,300 Added 1.68%	503,040 $1.95 Million
Q3 2017 Nov 13, 2017	BUY	$2.18 - $2.57 $1.08 Million - $1.27 Million	494,740	494,740 $1.26 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account